# Tenofovir-DF Versus Hydroxychloroquine in the Treatment of Hospitalized Patients With COVID-19 (TEDHICOV)

> **NCT04812496** · — · COMPLETED · sponsor: **Hospital Nacional Carlos Alberto Seguin Escobedo - EsSalud** · enrollment: 100 (actual)

## Conditions studied

- Covid19
- SARS-CoV Infection
- Tenofovir

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04812496
- **Lead sponsor:** Hospital Nacional Carlos Alberto Seguin Escobedo - EsSalud
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-01
- **Primary completion:** 2020-05-30
- **Final completion:** 2021-01-15
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2021-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04812496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04812496, "Tenofovir-DF Versus Hydroxychloroquine in the Treatment of Hospitalized Patients With COVID-19 (TEDHICOV)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04812496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*